Table 3.
Ratio of CD4+/CD8+ T-lymphocytes after vaccination and challenge.
| Group | Ratio of CD4+ and CD8+ T-lymphocytes |
||||
|---|---|---|---|---|---|
| 3 dpva | 7 dpv | 14 dpv | 21 dpv | 5 dpc | |
| rDEV-N | 0.80 ± 0.06b | 0.64 ± 0.06a | 0.72 ± 0.08 | 0.72 ± 0.09 | 0.72 ± 0.12 |
| rDEV-S | 0.92 ± 0.13 | 0.74 ± 0.10 | 0.85 ± 0.18 | 0.85 ± 0.14 | 0.89 ± 0.20 |
| rDEV-S1 | 0.82 ± 0.12 | 0.71 ± 0.08 | 0.82 ± 0.09 | 0.80 ± 0.14 | 0.80 ± 0.14 |
| rDEV-N & rDEV-S | 0.93 ± 0.16 | 0.73 ± 0.8.4 | 0.96 ± 0.24 | 0.81 ± 0.25 | 0.90 ± 0.33 |
| rDEV-N & rDEV-S1 | 0.82 ± 0.14 | 0.76 ± 0.08 | 0.87 ± 0.20 | 0.83 ± 0.15 | 0.89 ± 0.22 |
| Control | 0.87 ± 0.20 | 0.86 ± 0.17 | 0.92 ± 0.24 | 0.80 ± 0.19 | 0.86 ± 0.44 |
a
Days post-vaccination (dpv) or post-challenge (dpc). Statistically significant differences (p < 0.05) (compared to the control group).
b
Data are expressed as means ± standard deviations.